pa1010
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 28, 2020 (NCT05468060)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05019040 | Phase 1/Phase 2 (Phase 2) | Sep 17, 2021 | Tsinghua University, Zhejiang Palo Alto Pharmaceuticals, Inc. |
| NCT05468060 | Phase 1 | Jun 28, 2020 | Xuzhou Medical University, Zhejiang Palo Alto Pharmaceuticals, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zhejiang Palo Alto Pharmaceuticals, Inc. | For profit | 2 | 2 | 2 | 2020 |
| Tsinghua University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Xuzhou Medical University | Academic/Hospital | 1 | 0 | 1 | 2020 |
3 organizations
Page 1 / 1